More articles from Myeloproliferative Disorders

CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients
Bruno Cassinat, Emmanuelle Verger, Nabih Maslah, Nicolas Gauthier, William Vainchenker, Stéphane Giraudier, Jean-Jacques Kiladjian

Haematologica May 2020, haematol.2020.252643; DOI: 10.3324/haematol.2020.252643
Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation
Yoko Nishinaka-Arai, Akira Niwa, Shiori Matsuo, Yasuhiro Kazuki, Yuwna Yakura, Takehiko Hiroma, Tsutomu Toki, Tetsushi Sakuma, Takashi Yamamoto, Etsuro Ito, Mitsuo Oshimura, Tatsutoshi Nakahata, Megumu K. Saito

Haematologica Apr 2020, haematol.2019.242693; DOI: 10.3324/haematol.2019.242693
Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
JinJuan Yao, Lianrong Xu, Umut Aypar, Howard J. Meyerson, Dory Londono, Qi Gao, Jeeyeon Baik, James Dietz, Ryma Benayed, Allison Sigler, Mariko Yabe, Ahmet Dogan, Maria E. Arcila, Mikhail Roshal, Yanming Zhang, Michael J. Mauro, Wenbin Xiao

Haematologica Apr 2020, haematol.2020.249649; DOI: 10.3324/haematol.2020.249649
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Dustin Andersen Patel, Lise Mette Rahbek Gjerdrum, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Christina Ellervik, Niels Pallisgaard, Mads Thomassen, Lasse Kjær, Vibe Skov, Hans Carl Hasselbalch

Haematologica Jan 2020, haematol.2019.235648; DOI: 10.3324/haematol.2019.235648
Platelet-derived growth factor receptor β activation and regulation in murine myelofibrosis
Frederike Kramer, Jens Dernedde, Artur Mezheyeuski, Rudolf Tauber, Patrick Micke, Kai Kappert

Haematologica Oct 2019, haematol.2019.226332; DOI: 10.3324/haematol.2019.226332
Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
Samer A. Srour, Amanda Olson, Stefan O. Ciurea, Parth Desai, Qaiser Bashir, Betul Oran, Prithviraj Bose, Rohtesh Mehta, Keyur P. Patel, Naveen Pemmaraju, Naval Daver, Srdan Verstovsek, Richard E. Champlin, Uday R. Popat

Haematologica Jul 2019, haematol.2019.223503; DOI: 10.3324/haematol.2019.223503
JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury
Chi Hua Sarah Lin, Yu Zhang, Kenneth Kaushansky, Huichun Zhan

Haematologica Jul 2018, 103 (7) 1160-1168; DOI: 10.3324/haematol.2017.185736
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
Mathias Schneeweiss, Barbara Peter, Siham Bibi, Gregor Eisenwort, Dubravka Smiljkovic, Katharina Blatt, Mohamad Jawhar, Daniela Berger, Gabriele Stefanzl, Susanne Herndlhofer, Georg Greiner, Gregor Hoermann, Emir Hadzijusufovic, Karoline V. Gleixner, Peter Bettelheim, Klaus Geissler, Wolfgang R. Sperr, Andreas Reiter, Michel Arock, Peter Valent

Haematologica May 2018, 103 (5) 799-809; DOI: 10.3324/haematol.2017.179895
Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto

Haematologica Apr 2018, 103 (4) 607-613; DOI: 10.3324/haematol.2017.180448
Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study
Gunnar Birgegård, Carlos Besses, Martin Griesshammer, Luigi Gugliotta, Claire N. Harrison, Mohamed Hamdani, Jingyang Wu, Heinrich Achenbach, Jean-Jacques Kiladjian

Haematologica Jan 2018, 103 (1) 51-60; DOI: 10.3324/haematol.2017.174672

More articles from Myeloproliferative Disorders

Pages